BFRI Bathi mangsa ngarep Biofrontera

Biofrontera Inc. is expanding its reach through strategic alliances with leading US dermatological centers, confirming the projected volume of future profits. High physician confidence in the Ameluz system strengthens the brand's position, while strict medical protocols guarantee stable sales of high-margin components. The value of 0.01 indicates the company's current level of expected revenues.

Biofrontera Inc (BFRI): Prakiraan bathi perusahaan saka 22.03.2025 nganti 12.11.2026

BFRI (Biofrontera): rincian analitis lan laporan miturut indikator

- rega saham lan konsensus proyeksi valuasi:

Rega saham Biofrontera, Inc.|BFRI - Prakiraan konsensus analis

- data kapitalisasi pasar:

Biji pasar Biofrontera|BFRI - Nilai Dipunlarasaken Utang lan Kas

- informasi kapitalisasi buku:

Aset Bersih saben Siji Saham Biofrontera|BFRI - Pambiji Buku Bisnis|Rasio Nilai Pasar marang Nilai Buku biofrontera-us.com|BFRI - Total Aset Perusahaan

- indikator total utang lan likuiditas perusahaan:

Total Utang marang Modal Biofrontera Inc.|BFRI - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Biofrontera, Inc.|BFRI - Utang agregat perusahaan|Utang-utang marang kapitalisasi buku Biofrontera|BFRI - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Biofrontera|Likuiditas cepet biofrontera-us.com

- data bathi resik lan rasio valuasi:

BFRI - Penghasilan resik perusahaan|Proyeksi bathi mangsa ngarep Biofrontera Inc.|BFRI - Kapitalisasi marang bathi resik|Rega marang bathi mangsa ngarep Biofrontera, Inc.|BFRI - Koefisien bali modal nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Biofrontera|BFRI - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Biofrontera|BFRI - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan biofrontera-us.com|BFRI - Wutah bathi resik saben siji saham kanggo taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Biofrontera Inc.

Analisis umum perusahaan:Biofrontera Inc., BFRI

Biofrontera Inc. is optimizing costs by outsourcing ointment logistics to third-party operators. This indicator measures the dynamics of expected net income, synthesizing market forecasts into a daily data stream. The analyst distinguishes fundamental stability from volatility, assessing the smoothness of the trend as a sign of business maturity. The stability of these metrics confirms the effectiveness of seamless partner integration. Extrapolating future profits allows for an objective assessment of growth potential without time lags.

Pesaing wigati

KRYS (Krystal Biotech, Inc.) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep apogeetherapeutics.com|Bathi mangsa ngarep ARQT (Arcutis Biotherapeutics, Inc.)|VCEL (Vericel Corp) - Penghasilan resik sing dikarepake|Bathi sing dikarepake Oruka Corp ORKA|Prakiraan bathi perusahaan Sanara MedTech, Inc. (SMTI)|DBVT - Bathi sing dikarepake|SLSN - Proyeksi bathi mangsa ngarep|DERM: Proyeksi bathi mangsa ngarep|FBRX - Prakiraan bathi perusahaan|Bathi sing dikarepake Empro|Prakiraan bathi resik SLGL (Sol-Gel Technologies, Ltd.)|Proyeksi bathi mangsa ngarep AXIL|Bathi sing dikarepake MDCX (medicuspharma.com)|Proyeksi bathi mangsa ngarep VRCA (Verrica Pharmaceuticals Inc.)|Prakiraan bathi perusahaan Hoth Therapeutics Inc. (HOTH)|VYNE - Bathi sing dikarepake|Bathi resik sing dikarepake Sonoma Pharmaceuticals|QNRX: Proyeksi bathi mangsa ngarep|Bathi forward AZTR (azitrainc.com)|Bathi sing dikarepake Dermata Therapeutics, Inc.|ELAB: Penghasilan resik sing dikarepake|Bathi sing dikarepake Revance Therapeutics, Inc (RVNC)